ロード中...
Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth
There is currently no curative treatment for advanced renal cancer. Enhancing histone acetylation is a promising epigenetic-based therapy for cancer; however, in solid tumors, the efficacy of histone deacetylase (HDAC) inhibitors alone is limited. The human immunodeficiency virus protease inhibitor...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4179797/ https://ncbi.nlm.nih.gov/pubmed/25279191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.349 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|